Tata Memorial Centre signs MoU with Wipro GE Healthcare to establish ‘Cancer Research & Innovation Centre’

• MoU to collaborate on clinical research and academic engagement activities – set up a “Joint Working Group”  
• Joint Working Group to focus on key project areas and collaboration roadmap for the next 5 years

Bengaluru, India, 04 June, 2025: Tata Memorial Centre (TMC), a grant-in-aid institution under the jurisdiction
of Department of Atomic Energy, Government of India, today, signed a Memorandum of Understanding (MoU)
with GE HealthCare Technologies Inc., a leading global medical technology, pharmaceutical diagnostics, and
digital solutions innovator, to establish a state-of-the-art Cancer Research & Innovation Centre with GE
HealthCare as the technology partner and TMC as the clinical oncology partner. The collaboration aims to
strengthen clinical research and academic engagement activities with the establishment of a ‘Joint Working
Group’ to determine key project areas and collaboration roadmap for the next five years.
In India, around 100 out of every 1 lakh people are diagnosed with cancer 1 and a report from the Cancer Registry
Program states the incidence of cancer cases is estimated to increase by 12.8% in 2025 as compared to 2020 2 .
The alarming statistics underscore the need for precision-driven, AI-enabled solutions to advance cancer care.
Dr. C. S. Pramesh, Director of Tata Memorial Hospital says, “The government is adopting a strategic, policy-
driven approach to fight cancer with the establishment of day care centres, expansion of cancer care ecosystem,
promoting cancer screenings and awareness programmes. However, early detection, equitable access and
preventive care remain a challenge. GE HealthCare is a world leader in MedTech and as partners, we aim to
enhance clinical research and promote academic engagement to transform personalized cancer care for
improved outcomes cancer care.”
Chaitanya Sarawate, President and CEO, GE HealthCare South Asia says, “In India, the estimated number of
incidences of cancer cases was more than 14 lakhs in 2023. 3 With oncology as a focus for us at GE HealthCare,
globally, our innovations enable precision-led cancer care through an eco-system of devices and digital
solutions powered by AI. We are proud to partner with industry leaders like Tata Memorial Centre, who are
among the leaders in the fight against cancer with their expertise in research, service and education, providing
comprehensive cancer care to the last citizen. With TMC, we will strengthen our commitment to deliver solutions
that connect every step of cancer care right from discovery, diagnosis to treatment, with the integration of
advanced imaging technologies and AI-led solutions.”
The partnership aims to accelerate the development and validation of emerging technologies and digital
platforms in Oncology – on AI-based applications for medical imaging, clinical workflows, hardware and
software for advanced-visualization to post-process and analyse medical images. The scope also includes vetted
data annotations for application-development, enterprise applications for health informatics and management
to drive optimization and transform personalized cancer care for improved outcomes.